Triple positive breast cancer: A distinct subtype?-Reference-Cited by-同舟云学术

Triple positive breast cancer: A distinct subtype?

Published:2015-02 Issue:2 Volume:41 Page:69-76
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Vici Patrizia,Pizzuti Laura,Natoli Clara,Gamucci Teresa,Di Lauro Luigi,Barba Maddalena,Sergi Domenico,Botti Claudio,Michelotti Andrea,Moscetti Luca,Mariani Luciano,Izzo Fiorentino,D’Onofrio Loretta,Sperduti Isabella,Conti Francesca,Rossi Valentina,Cassano Alessandra,Maugeri-Saccà Marcello,Mottolese Marcella,Marchetti Paolo

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference85 articles.

1. Molecular portraits of human breast tumours;Perou;Nature,2000

2. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

3. Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology, and end results database;Anderson;Breast Cancer Res Treat,2002

4. Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy;Cui;J Clin Oncol,2005

5. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype;Rakha;J Clin Oncol,2007

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Insight for Axillary De-Escalation in Breast Cancer Surgery: “SoFT Study” Retrospective Analysis;Current Oncology;2024-07-23

2. Evolving Management of Breast Cancer in the Era of Predictive Biomarkers and Precision Medicine;Journal of Personalized Medicine;2024-07-03

3. Efficacy of Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer;American Journal of Clinical Oncology;2024-06-21

4. A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple‐positive breast cancer;MedComm;2024-03

5. Discovery of a proliferation essential gene signature and actin‐like 6A as potential biomarkers for predicting prognosis and neoadjuvant chemotherapy response in triple‐positive breast cancer;Cancer;2024-02-15